Influence of omeprazol on the antiplatelet action of clopidogrel associated to aspirin

J Thromb Haemost. 2006 Nov;4(11):2508-9. doi: 10.1111/j.1538-7836.2006.02162.x. Epub 2006 Aug 8.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Angioplasty / adverse effects
  • Angioplasty / methods
  • Aryl Hydrocarbon Hydroxylases / antagonists & inhibitors
  • Aryl Hydrocarbon Hydroxylases / genetics
  • Aryl Hydrocarbon Hydroxylases / metabolism
  • Aspirin / antagonists & inhibitors*
  • Aspirin / pharmacology
  • Cell Adhesion Molecules / metabolism*
  • Clopidogrel
  • Coronary Disease / complications
  • Coronary Disease / genetics
  • Coronary Disease / metabolism*
  • Coronary Disease / surgery
  • Cytochrome P-450 CYP2C19
  • Drug Antagonism
  • Enzyme Inhibitors / pharmacology
  • Female
  • Humans
  • Male
  • Microfilament Proteins / metabolism*
  • Mixed Function Oxygenases / antagonists & inhibitors
  • Mixed Function Oxygenases / genetics
  • Mixed Function Oxygenases / metabolism
  • Omeprazole / antagonists & inhibitors*
  • Omeprazole / pharmacology
  • Phosphoproteins / metabolism*
  • Phosphorylation / drug effects
  • Platelet Activation / drug effects*
  • Platelet Activation / genetics
  • Platelet Aggregation Inhibitors / pharmacology
  • Platelet Function Tests / methods
  • Polymorphism, Single Nucleotide
  • Protein Processing, Post-Translational / drug effects
  • Thrombosis / etiology
  • Thrombosis / genetics
  • Thrombosis / metabolism
  • Ticlopidine / analogs & derivatives*
  • Ticlopidine / antagonists & inhibitors
  • Ticlopidine / pharmacology

Substances

  • Cell Adhesion Molecules
  • Enzyme Inhibitors
  • Microfilament Proteins
  • Phosphoproteins
  • Platelet Aggregation Inhibitors
  • vasodilator-stimulated phosphoprotein
  • Clopidogrel
  • Mixed Function Oxygenases
  • Aryl Hydrocarbon Hydroxylases
  • CYP2C19 protein, human
  • Cytochrome P-450 CYP2C19
  • Omeprazole
  • Ticlopidine
  • Aspirin